These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28081037)

  • 21. Unchanged Levels of Soluble CD14 and IL-6 Over Time Predict Serious Non-AIDS Events in HIV-1-Infected People.
    Sunil M; Nigalye M; Somasunderam A; Martinez ML; Yu X; Arduino RC; Utay NS; Bell TK
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1205-1209. PubMed ID: 27344921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection.
    Kirkegaard-Klitbo DM; Mejer N; Knudsen TB; Møller HJ; Moestrup SK; Poulsen SD; Kronborg G; Benfield T
    AIDS; 2017 Apr; 31(7):981-988. PubMed ID: 28252527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.
    Kawarabayashi R; Motoyama K; Nakamura M; Yamazaki Y; Morioka T; Mori K; Fukumoto S; Imanishi Y; Shioi A; Shoji T; Emoto M; Inaba M
    J Diabetes Res; 2017; 2017():6549242. PubMed ID: 29445750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
    Lund Laursen T; Brøckner Siggard C; Kazankov K; Damgaard Sandahl T; Møller HJ; Ong A; Douglas MW; George J; Tarp B; Hagelskjaer Kristensen L; Lund Laursen A; Hiramatsu A; Nakahara T; Chayama K; Grønbaek H
    Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
    Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
    J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
    J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
    Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
    J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
    Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
    PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
    Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.
    Carreras-Badosa G; Prats-Puig A; Diaz-Roldan F; Platero-Gutierrez E; Osiniri I; Riera-Perez E; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
    Pediatr Obes; 2016 Dec; 11(6):543-550. PubMed ID: 26843034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
    Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
    J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
    Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis.
    Sun H; Jiang R; Han B; Du X; Ma C; Xu Y; Chen Z; Wang L; Yang S; Lv X; Zhao H; Li X
    J Infect Dev Ctries; 2019 Aug; 13(8):714-719. PubMed ID: 32069255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.